معرفی
Shan Xin is a Researcher at Yale School of Medicine, Yale University. Their work focuses on cancer immunotherapy, ferroptosis mechanisms, and CRISPR-based technologies. Key projects include developing combinatorial immunotherapies using Cas13d to target immunosuppressive genes, analyzing macrophage roles in cancer therapy resistance, and exploring lipid metabolic pathways in ferroptosis regulation. Collaborations involve Sidi Chen, Hongyu Zhao, and Paul Renauer. Research spans single-cell profiling, multiomics analysis, and engineering T cells for immunotherapy. No scientific awards are explicitly mentioned, and advising/grant details are not provided in available texts.
۰مقاله منتشرشده
